Kirkland Represents GTCR and Corza Health on Acquisition of TachoSil Surgical Patch from Takeda

Kirkland represents GTCR and Corza Health, Inc., on the acquisition of TachoSil® Fibrin Sealant Patch from Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK). Corza Health was formed in 2019 as a partnership between private equity firm GTCR and healthcare industry veteran Gregory T. Lucier to build a market-leading healthcare business with a particular focus on the broader medical technology and life sciences sector. Takeda will receive €350 million in cash upon closing of the transaction, which is subject to customary legal and regulatory closing conditions.

Read the press release from Takeda

The Kirkland team was led by transactional partners Jacob Traff, Christopher Thomas, Michael Weed, Sanford Perl and David Higgins.